Impact of sex differences in immune function on shared risk for cardiometabolic disorder & Alzheimer — JILL M GOLDSTEIN (MASSACHUS
Summary By 2050, approximately 13.8 million people in the U.S. are projected to have Alzheimer's disease (AD), two- thirds of whom will be women. Secondary to genetics, cardiometabolic diseases (CMD),
| Project title | Impact of sex differences in immune function on shared risk for cardiometabolic disorder & Alzheimer |
|---|---|
| Project number | 1RF1AG074008-01 |
| PI name | JILL M GOLDSTEIN |
| Institution | MASSACHUSETTS GENERAL HOSPITAL |
| Funding mechanism | RF1 |
| Agency | NIA |
| Award amount | $3.79M |
| Fiscal year | 2021 |
| Project start | 2021-09-30T00:00:00 |
| Project end | 2024-08-31T00:00:00 |
| Abstract | Summary By 2050, approximately 13.8 million people in the U.S. are projected to have Alzheimer's disease (AD), two- thirds of whom will be women. Secondary to genetics, cardiometabolic diseases (CMD), |
| Key terms | <AD dementia><Age><Alzheimer><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease><Al |
$799/mo
Try GrantRadar →